Evidence map›Paper›PMID 28916473›Full record

ArticleFree radical biology & medicine2017

Down-regulation of NOX2 activity in phagocytes mediated by ATM-kinase dependent phosphorylation.

Sylvain Beaumel, Antoine Picciocchi, Franck Debeurme, Corinne Vivès, Anne-Marie Hesse, Myriam Ferro, Didier Grunwald, Heather Stieglitz, Pahk Thepchatri, Susan M E Smith and 2 more

Abstract read
In one paragraph

Article in Free radical biology & medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Sylvain BeaumelUniv. Grenoble Alpes, CNRS, TIMC-IMAG, F-38000 Grenoble, France; CDiReC, Pôle Biologie, CHU de Grenoble, Grenoble F-38043, France.
Antoine PicciocchiUniv. Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale, F-38044 Grenoble, France.
Franck DebeurmeUniv. Grenoble Alpes, CNRS, TIMC-IMAG, F-38000 Grenoble, France.
Corinne VivèsUniv. Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale, F-38044 Grenoble, France.
Anne-Marie HesseUniv. Grenoble Alpes, INSERM, CEA, Laboratoire de Biologie à Grande Echelle, Grenoble F-38054, France; Univ. Grenoble Alpes, CEA, INSERM, Laboratoire de Biologie du Cancer et de l'infection, Grenoble F-38000, France.
Myriam FerroUniv. Grenoble Alpes, INSERM, CEA, Laboratoire de Biologie à Grande Echelle, Grenoble F-38054, France.
Didier GrunwaldUniv. Grenoble Alpes, CEA, INSERM, Laboratoire de Biologie du Cancer et de l'infection, Grenoble F-38000, France.
Heather StieglitzDepartment of Molecular and Cellular Biology, Kennesaw State University, Kennesaw, GA, USA.
Pahk ThepchatriDepartment of Molecular and Cellular Biology, Kennesaw State University, Kennesaw, GA, USA.
Susan M E SmithDepartment of Molecular and Cellular Biology, Kennesaw State University, Kennesaw, GA, USA.
Franck FieschiUniv. Grenoble Alpes, CNRS, CEA, Institut de Biologie Structurale, F-38044 Grenoble, France.
Marie José StasiaUniv. Grenoble Alpes, CNRS, TIMC-IMAG, F-38000 Grenoble, France; CDiReC, Pôle Biologie, CHU de Grenoble, Grenoble F-38043, France. Electronic address: mjstasia@chu-grenoble.fr.
Kennesaw State University · USCentre Hospitalier Universitaire de Grenoble · FRUniversité Grenoble Alpes · FRCEA Grenoble · FRCentre National de la Recherche Scientifique · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FR

Funding

PRIMARY IMMUNODEFICIENCY DISEASE REGISTRY-266030070-266030070N01AI030070 · NIAID · PIRC, INC. · 2003 to 2005
–
NIAID NIH HHS N01 AI030070
6 · The paper itself

Abstract

NADPH oxidases (NOX) have many biological roles, but their regulation to control production of potentially toxic ROS molecules remains unclear. A previously identified insertion sequence of 21 residues (called NIS) influences NOX activity, and its predicted flexibility makes it a good candidate for providing a dynamic switch controlling the NOX active site. We constructed NOX2 chimeras in which NIS had been deleted or exchanged with those from other NOXs (NIS1, 3 and 4). All contained functional heme and were expressed normally at the plasma membrane of differentiated PLB-985 cells. However, NOX2-ΔNIS and NOX2-NIS1 had neither NADPH-oxidase nor reductase activity and exhibited abnormal translocation of p47

Indexed as

Gene Expression RegulationProtein Processing, Post-TranslationalAtaxia Telangiectasia Mutated ProteinsCell Line, TumorDown-RegulationHumansNADPH Oxidase 2PhagocytesPhosphorylationSignal TransductionAtaxia Telangiectasia Mutated ProteinsATM protein, humanCYBB protein, humanNADPH Oxidase 2Ataxia telangiectasia mutated (ATM)NADPH oxidaseNeutrophilNOXNOX-specific Insertion Sequence (NIS)Phosphorylation

Identifiers

PMID28916473
PMCPMC5699957
OpenAlexW2753941724

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.